Neubond
Imperial College London spinout developing a wristband that delivers targeted electrical stimulation to aid stroke patients' motor recovery.
Last refreshed: 24 June 2026 · Appears in 1 active topic
How does Neubond's electrical stimulation wristband differ from standard stroke physiotherapy?
Timeline for Neubond
Raised £1.5m seed from a Japanese university venture fund
UK Startups and Innovation: Neubond seed is Japan VC's UK firstBackground
Neubond raised a £1.5m seed in June 2026 in what has been described by a trade outlet as the first UK investment made by a Japanese university venture fund, though the investor is not independently named and the cross-border-first claim is attributed to a single source.
An Imperial College London spinout, Neubond's core device is a wristband. When a stroke patient attempts to move a limb, the device senses the neural signal and delivers a small electrical pulse to the relevant muscle, reinforcing the nerve pathway and accelerating motor relearning. The company reached seed stage via Innovate UK's ICURe commercialisation programme, Imperial's own venture support infrastructure, and a European Research Council proof-of-concept award.
Stroke is among the leading causes of long-term disability globally, and current physiotherapy is resource-intensive and slow. If Neubond's approach demonstrates clinical efficacy at scale, the addressable market is large. The company remains at an early, pre-clinical commercial stage.
